266 related articles for article (PubMed ID: 12144577)
1. Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
Isakov V; Domareva I; Koudryavtseva L; Maev I; Ganskaya Z
Aliment Pharmacol Ther; 2002 Jul; 16(7):1277-82. PubMed ID: 12144577
[TBL] [Abstract][Full Text] [Related]
2. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
3. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.
Laine L; Hunt R; El-Zimaity H; Nguyen B; Osato M; Spénard J
Am J Gastroenterol; 2003 Mar; 98(3):562-7. PubMed ID: 12650788
[TBL] [Abstract][Full Text] [Related]
4. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Gisbert JP; Gisbert JL; Marcos S; Grávalos RG; Carpio D; Pajares JM
Aliment Pharmacol Ther; 1999 Oct; 13(10):1311-6. PubMed ID: 10540045
[TBL] [Abstract][Full Text] [Related]
5. Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
Nie Y; Li Y; Wu H; Sha W; Du H; Dai S; Wang H; Li Q
Helicobacter; 1999 Jun; 4(2):128-34. PubMed ID: 10382127
[TBL] [Abstract][Full Text] [Related]
6. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Fakheri H; Malekzadeh R; Merat S; Khatibian M; Fazel A; Alizadeh BZ; Massarrat S
Aliment Pharmacol Ther; 2001 Mar; 15(3):411-6. PubMed ID: 11207517
[TBL] [Abstract][Full Text] [Related]
7. Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease.
Malekzadeh R; Ansari R; Vahedi H; Siavoshi F; Alizadeh BZ; Eshraghian MR; Vakili A; Saghari M; Massarrat S
Aliment Pharmacol Ther; 2000 Mar; 14(3):299-303. PubMed ID: 10735922
[TBL] [Abstract][Full Text] [Related]
8. Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for
Bang CS; Lim H; Jeong HM; Shin WG; Choi JH; Soh JS; Kang HS; Yang YJ; Hong JT; Shin SP; Suk KT; Lee JJ; Baik GH; Kim DJ
Gut Microbes; 2020 Sep; 11(5):1314-1323. PubMed ID: 32362221
[TBL] [Abstract][Full Text] [Related]
9. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.
Liu WZ; Xiao SD; Shi Y; Wu SM; Zhang DZ; Xu WW; Tytgat GN
Aliment Pharmacol Ther; 1999 Mar; 13(3):317-22. PubMed ID: 10102964
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
11. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
Xiao SD; Liu WZ; Hu PJ; Xia DH; Tytgat GN
Aliment Pharmacol Ther; 1999 Mar; 13(3):311-5. PubMed ID: 10102963
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
[TBL] [Abstract][Full Text] [Related]
13. Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
Sotoudehmanesh R; Malekzadeh R; Vahedi H; Dariani NE; Asgari AA; Massarrat S
Digestion; 2001; 64(4):222-5. PubMed ID: 11842278
[TBL] [Abstract][Full Text] [Related]
14. Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study.
Zhang Y; Gao W; Cheng H; Zhang X; Hu F
Helicobacter; 2014 Oct; 19(5):382-6. PubMed ID: 24849129
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.
Mantzaris GJ; Petraki K; Archavlis E; Amberiadis P; Christoforidis P; Kourtessas D; Chiotakakou E; Triantafyllou G
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1237-43. PubMed ID: 12439119
[TBL] [Abstract][Full Text] [Related]
16. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
[TBL] [Abstract][Full Text] [Related]
17. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
Mirbagheri SA; Hasibi M; Abouzari M; Rashidi A
World J Gastroenterol; 2006 Aug; 12(30):4888-91. PubMed ID: 16937475
[TBL] [Abstract][Full Text] [Related]
18. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication.
van der Hulst RW; van der Ende A; Homan A; Roorda P; Dankert J; Tytgat GN
Gut; 1998 Feb; 42(2):166-9. PubMed ID: 9536938
[TBL] [Abstract][Full Text] [Related]
19. Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.
Khatibian M; Ajvadi Y; Nasseri-Moghaddam S; Ebrahimi-Dariani N; Vahedi H; Zendehdel N; Sotoudehmanesh R; Agah S; Mikaeli J; Pourshams A; Ali-Asgari A; Malekzadeh R; Massarrat S
Arch Iran Med; 2007 Apr; 10(2):161-7. PubMed ID: 17367217
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.
Sotudehmanesh R; Malekzadeh R; Fazel A; Massarrat S; Ziad-Alizadeh B; Eshraghian MR
J Gastroenterol Hepatol; 2001 Mar; 16(3):264-8. PubMed ID: 11339416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]